Intraparietal esophageal leiomyomas diagnosed by endoscopic ultrasound‑guided fine‑needle aspiration cytology: Cytological and immunocytochemical features in two cases

Todaro,P.; Crinò,S. F.; Ieni,A.; Pallio,S.; Consolo,P.; Tuccari,G.

doi:10.3892/ol.2014.2077

Intraparietal esophageal leiomyomas diagnosed by endoscopic ultrasound‑guided fine‑needle aspiration cytology: Cytological and immunocytochemical features in two cases

Authors:
- P. Todaro
- S. F. Crinò
- A. Ieni
- S. Pallio
- P. Consolo
- G. Tuccari
View Affiliations

Affiliations: Department of Human Pathology ‘Gaetano Barresi’, Hospital Health Network ‘Polyclinic G. Martino’, University of Messina, Messina, I‑98125 Italy, Digestive Endoscopy Unit, Hospital Health Network ‘Polyclinic G. Martino’, University of Messina, Messina, I‑98125 Italy
Published online on: April 16, 2014 https://doi.org/10.3892/ol.2014.2077
Pages: 123-126

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endoscopic ultrasound‑guided fine‑needle aspiration cytology (EUS‑FNAC) has proven to be of significant value as a diagnostic method for the evaluation of esophageal mesenchymal tumors, such as true leiomyomas. Utilizing the cell block procedure, the present study reports the diagnostic approach of EUS‑FNAC in two patients affected by this lesion, describing the cytological and immunocytochemical findings. Spindle‑shaped elements with elongated nuclei were appreciable; moreover, the cytoplasmatic immunohistochemical positivity for smooth muscle actin and desmin strongly supported the diagnosis of leiomyoma when also taking into account the constant negativity for CD34, CD117 and S100. The differential diagnosis between spindle cell mesenchymal tumors and leiomyomas, and the clinico‑therapeutic management of the latter are also discussed in the study.

View Figures

View References

1	Matsui M, Goto H, Niwa Y, Arisawa T, Hirooka Y and Hayakawa T: Preliminary results of fine needle aspiration biopsy histology in upper gastrointestinal submucosal tumors. Endoscopy. 30:750–755. 1998.
2	Miettinen M, Sarlomo-Rikala M, Sobin LH and Lasota J: Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparson with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 24:211–222. 2000.
3	Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH and Lasota J: Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 25:1121–33. 2001.
4	Wieczorek TJ, Faquin WC, Rubin BP and Cibas ES: Cytologic diagnosis of gastrointestinal stromal tumor with emphasis on the differential diagnosis with leiomyosarcoma. Cancer. 93:276–287. 2001.
5	Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T and Hayakawa T: The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc. 55:37–43. 2002.
6	Trupiano JK, Stewart RE, Misick C, Appelman HD and Goldblum JR: Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol. 26:705–714. 2002.
7	Stelow EB, Stanley MW, Mallery S, Lai R, Linzie BM and Bardales RH: Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol. 119:703–708. 2003.
8	Stelow EB, Jones DR and Shami VM: Esophageal leiomyosarcoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol. 35:167–170. 2007.
9	Jenssen C and Dietrich CF: Endoscopic ultrasound-guided fine-needle aspiration biopsy and trucut biopsy in gastroenterology - An overview. Brest Pract Res Clin Gastroenterol. 23:743–759. 2009.
10	Fletcher CD, Berman JJ, Corless C, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 33:459–465. 2002.
11	Blay JY, Bonvalot S, Casali P, et al; GIST consensus meeting panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO. Ann Oncol. 16:566–578. 2005.
12	Nilsson B, Bümming P, Meis-Kindblom JM, et al: Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - a population-based study in western Sweden. Cancer. 103:821–829. 2005.
13	Blanke CD, Demetri GD, von Mehren M, et al: Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol. 26:620–625. 2008.
14	Maheshwari V, Alam K, Varshney M, Jain A, Asif Siddiqui F and Bhargava S: Fine-needle aspiration diagnosis of GIST: a diagnostic dilemma. Diagn Cytopathol. 40:834–838. 2012.
15	Todaro P, Crinò SF, Pallio S, Fazzari C, Consolo P and Tuccari G: Gastrointestinal stromal tumors of the stomach: Cytological and immunocytochemical diagnostic features of two cases diagnosed by endoscopic ultrasound-guided fine needle aspiration. Oncol Lett. 5:1862–1866. 2013.
16	Nathan NA, Narayan E, Smith MM and Horn MJ: Cell block cytology. Improved preparation and its efficacy in diagnostic cytology. Am J Clin Pathol. 114:599–606. 2000.
17	Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffrè G, Guiducci G, Tuccari G and Barresi G: Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropathol. 112:617–626. 2006.
18	Yoshinaga S, Suzuki H, Oda I and Saito Y: Role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for diagnosis of solid pancreatic masses. Dig Endosc. 23(Suppl 1): 29–33. 2011.
19	Wong DW, Lupton SC, Bhatt L, Gross L, Tanière P, Peake DR, Spooner D and Geh JI: Use of imatinib mesylate in gastrointestinal stromal tumors: Pan-Birmingham Cancer Network experience. Clin Oncol (R Coll Radiol). 20:517–522. 2008.
20	Reid R, O’Dywer P, MacDuff E, et al: Guidelines for the management of gastrointestinal stromal tumors (GIST) in Scotland. pp. 53–55. 2009, http://www.pathologyscotland.org/download/sgpg/guidelines/gist.pdf. Accessed November 13, 2012
21	Jiang W, Rice TW and Goldblum JR: Esophageal leiomyoma: experience from a single institution. Dis Esophagus. 26:167–174. 2013.
22	Choi SH, Kim YT, Han KN, Ra YJ, Kang CH, Sung SW and Kim JH: Surgical management of the esophageal leiomyoma: lessons from a retrospective review. Dis Esophagus. 24:325–329. 2011.
23	Xu GQ, Qian JJ, Chen MH, Ren GP and Che HT: Endoscopic ultrasonography for the diagnosis and selecting treatment of esophageal leiomyoma. J Gastroenterol Hepatol. 27:521–525. 2012.
24	Hatch GF 3rd, Wertheimer-Hatch L, Hatch KF, Davis GB, Blanchard DK, Foster RS Jr and Skandalakis JE: Tumors of the esophagus. World J Surg. 24:401–411. 2000.
25	Lee LS, Singhal S, Brinster CJ, Marshall B, Kochman ML, Kaiser LR and Kucharczuk JC: Current management of esophageal leiomyoma. J Am Coll Surg. 198:136–146. 2004.
26	Maish M: Esophagus. Sabiston Textbook of Surgery. Townsend CM Jr, Beauchamp RD, Ever BM and Mattox KL: 18th edition. Saunders; Philadelphia, PA: pp. 1087–1088. 2007
27	Jiang G, Zhao H, Yang F, Li J, Li Y, Liu Y, Liu J and Wang J: Thoracoscopic enucleation of esophageal leiomyoma: a retrospective study on 40 cases. Dis esophagus. 22:279–283. 2009.